https://www.selleckchem.com/products/IC-87114.html
6% received moderate-/low-intensity LLTs during the 6months after the index event. The first year CV event rate was 18.0/100 patient-years for patients receiving high-intensity LLTs and 17.2/100 patient-years for those on moderate-/low-intensity LLTs. Higher costs were associated with patients untreated with LLT 6months post-index event (€8323) than patients prescribed high-intensity (€6278) or moderate-/low-intensity LLTs (€627. Hospitalization accounted for most of the total costs. This study found that CV events in secondary preve
Like
Comment
Share
